Our people
What we do
Sectors Practices Legal Tech

Aerospace and Defense

Automotive and Mobility

Consumer

Education

Energy and Natural Resources

Financial Institutions

Insurance

Life Sciences and Health Care

Manufacturing and Industrials

Private Capital

Real Estate

Sports, Media and Entertainment

Technology and Telecoms

Transportation and Logistics

Corporate & Finance

Disputes

Intellectual Property

Regulatory
Case studies
Our thinking
All Our thinking

Comparative guides

Digital Client Solutions

Events and webinars

Podcasts

News

Hogan Lovells 2024 Election Impact and Congressional Outlook Report
ESG
Careers

Search

Search

English

Deutsch
English
Español
Français
日本語
中文

False

About us
Where we are
Media center
Responsible Business
Alumni

Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Resources

Premium services

Click here to learn more about our range of premium tools

Distressed Banks

Navigate the legal implications relating to banks in distress with our resource center.

Supply Chains

Access our latest insights into supply chain risk management and governance.

Comparative guides

View the global picture with our interactive comparative guides

Publications

Search

No results found

Clear all

2

Type

Filter by type

Insights and Analysis
News

Sectors

Aerospace and Defense
Automotive and Mobility
Consumer
Education
Energy and Natural Resources
Financial Institutions
Life Sciences and Health Care
Manufacturing and Industrials
Private Capital
Sports, Media and Entertainment
Technology and Telecoms
Transportation and Logistics

Practices

Topic

China Trade and Security
Data Centers
ESG, Sustainability, and Climate
European Green Deal
Supply Chain Legal Issues

Year

2024
2023
2022
2021

News

Don’t sleep on trademarks! – The importance of trademark registration for pharma products in the EU

08 November 2024

News

Q3/2024 Life Science Law Update – Key developments for pharma & device companies in EU

31 October 2024

News

Regulation for medicines manufactured at the point of care introduced before UK Parliament

25 October 2024

News

FDA lists top 10 artificial intelligence regulatory concerns

21 October 2024

News

Safe and correct use of food in interventional human studies

11 October 2024

News

Final FDA electronic systems guidance offers greater compliance flexibility

09 October 2024

News

How does the AI Act apply to clinical investigations of AIMD?

08 October 2024

News

Rare pediatric disease Priority Review Voucher program renewed through Dec. 20

04 October 2024

News

New FDA clinical trials guidances promote efficient drug development, innovative designs, diversity

20 September 2024

Load more

rightarrow

Contact us

About us
Careers
Case studies
Contact us
Diversity, Equity & Inclusion
Our people
Our thinking
Responsible Business

Cookies
Disclaimer
Fraudulent and Scam Emails
Legal notices
Modern Slavery Statement
Our thinking terms of use
Privacy
RSS

Connect with us

rightarrow

Subscribe to Our thinking

© 2024 Hogan Lovells. All rights reserved. "Hogan Lovells" or the “firm” refers to the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses, each of which is a separate legal entity. Attorney advertising. Prior results do not guarantee a similar outcome.